IL42016A - History of dopamine and their preparation - Google Patents

History of dopamine and their preparation

Info

Publication number
IL42016A
IL42016A IL42016A IL4201673A IL42016A IL 42016 A IL42016 A IL 42016A IL 42016 A IL42016 A IL 42016A IL 4201673 A IL4201673 A IL 4201673A IL 42016 A IL42016 A IL 42016A
Authority
IL
Israel
Prior art keywords
methyl
hydrogen
phenethylamine
methoxylated
propyl7
Prior art date
Application number
IL42016A
Other languages
English (en)
Hebrew (he)
Other versions
IL42016A0 (en
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22918877&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL42016(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of IL42016A0 publication Critical patent/IL42016A0/xx
Publication of IL42016A publication Critical patent/IL42016A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
    • C07C211/26—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/45—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by condensation
    • C07C45/46—Friedel-Crafts reactions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cardiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL42016A 1972-04-12 1973-04-12 History of dopamine and their preparation IL42016A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US24346672A 1972-04-12 1972-04-12

Publications (2)

Publication Number Publication Date
IL42016A0 IL42016A0 (en) 1973-06-29
IL42016A true IL42016A (en) 1976-05-31

Family

ID=22918877

Family Applications (1)

Application Number Title Priority Date Filing Date
IL42016A IL42016A (en) 1972-04-12 1973-04-12 History of dopamine and their preparation

Country Status (31)

Country Link
JP (2) JPS5825656B2 (fr)
KR (1) KR790000113B1 (fr)
AR (1) AR203822A1 (fr)
AT (1) AT323719B (fr)
AU (1) AU472734B2 (fr)
BE (1) BE798051A (fr)
BG (1) BG23001A3 (fr)
CA (1) CA1018188A (fr)
CH (2) CH580563A5 (fr)
CS (2) CS190406B2 (fr)
CY (1) CY963A (fr)
DD (1) DD107670B3 (fr)
DE (1) DE2317710C2 (fr)
DK (1) DK142750C (fr)
ES (1) ES413639A1 (fr)
FR (1) FR2182947B1 (fr)
GB (1) GB1392674A (fr)
HK (1) HK50178A (fr)
HU (2) HU167597B (fr)
IE (1) IE37511B1 (fr)
IL (1) IL42016A (fr)
KE (1) KE2870A (fr)
MY (1) MY7800381A (fr)
NL (1) NL174459C (fr)
PH (1) PH11041A (fr)
PL (2) PL90695B1 (fr)
RO (2) RO70892A (fr)
SE (1) SE399064B (fr)
SU (1) SU496719A3 (fr)
YU (2) YU36483B (fr)
ZA (1) ZA732136B (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH585693A5 (fr) * 1974-02-08 1977-03-15 Ciba Geigy Ag
US4342692A (en) * 1980-10-20 1982-08-03 Usv Pharmaceutical Corporation Pyrrolidines
NO822514L (no) * 1981-07-22 1983-01-24 Syntex Inc Fremgangsmaate ved fremstilling av terapeutisk virksomme 2,5-substituerte pyrrolidinderivater
JPS6061523A (ja) * 1983-09-16 1985-04-09 Shionogi & Co Ltd 経口用ドブタミン製剤
IL85438A0 (en) * 1987-02-24 1988-07-31 Lilly Co Eli Improvements in or relating to dobutamine salts
JPH0383364U (fr) * 1989-12-18 1991-08-23
AU658188B2 (en) * 1991-05-20 1995-04-06 Tsumura & Co. Phellodendrine analogs and allergy type IV suppressor containing the same as active ingredient
EP0620208B1 (fr) * 1993-04-13 1997-07-09 Duphar International Research B.V Production de composés de la dobutamine
ATE155125T1 (de) * 1993-04-13 1997-07-15 Duphar Int Res Herstellung von dobutamin verbindungen
ES2535975T3 (es) 2002-10-03 2015-05-19 Novaremed Ltd. Compuestos para su uso en el tratamiento de enfermedades autoinmunitarias, enfermedades inmunoalérgicas y rechazo de trasplantes de órganos o tejidos
JP4939396B2 (ja) * 2004-03-26 2012-05-23 ノヴァレメッド リミテッド Ａｉｄｓ及び他のウイルス性疾患及びｈｉｖ関連感染症の改善又はその治療用化合物及びそのような化合物を含む組成物、そのような疾患及び感染症の治療方法及びそのような化合物及び組成物の製造方法
GB0804213D0 (en) 2008-03-06 2008-04-16 New Era Biotech Ltd A method of printing or preventing pain
JP2013501006A (ja) 2009-07-31 2013-01-10 コグニション セラピューティクス インク． 認知機能低下の阻害剤
US8802734B2 (en) 2009-09-09 2014-08-12 Novaremed Limited Method of treating or preventing pain
US20170197977A9 (en) * 2011-08-25 2017-07-13 Cognition Therapeutics, Inc. Compositions and methods for treating neurodegenerative disease
ES2721001T3 (es) 2014-01-31 2019-07-26 Cognition Therapeutics Inc Derivado de isoindolina, y composiciones y métodos para tratar una enfermedad neurodegenerativa
EP3634394A4 (fr) 2017-05-15 2021-04-07 Cognition Therapeutics, Inc. Compositions pour le traitement de maladies neurodégénératives
CN114524734B (zh) * 2021-12-27 2024-04-26 嘉实（湖南）医药科技有限公司 一种盐酸多巴酚丁胺的制备方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2276619A (en) * 1942-03-17 N-phentlaliphatic-dihtoroxyphentnl

Also Published As

Publication number Publication date
YU37113B (en) 1984-08-31
NL174459B (nl) 1984-01-16
NL174459C (nl) 1984-06-18
PL90695B1 (fr) 1977-01-31
MY7800381A (en) 1978-12-31
HU166213B (fr) 1975-02-28
NL7305097A (fr) 1973-10-16
KE2870A (en) 1978-09-01
IE37511B1 (en) 1977-08-03
CS190448B2 (en) 1979-05-31
CA1018188A (en) 1977-09-27
RO65105A (fr) 1980-01-15
HK50178A (en) 1978-09-15
ZA732136B (en) 1974-03-27
AU5438573A (en) 1974-10-17
BE798051A (fr) 1973-10-11
CH580563A5 (fr) 1976-10-15
ES413639A1 (es) 1976-01-16
DD107670B3 (de) 1988-04-06
DD107670A5 (de) 1974-08-12
CY963A (en) 1978-12-22
YU36483B (en) 1984-02-29
IL42016A0 (en) 1973-06-29
FR2182947B1 (fr) 1976-07-02
KR790000113B1 (en) 1979-03-20
JPS5825656B2 (ja) 1983-05-28
DE2317710A1 (de) 1973-10-18
FR2182947A1 (fr) 1973-12-14
DK142750C (da) 1981-08-17
AT323719B (de) 1975-07-25
GB1392674A (en) 1975-04-30
DE2317710C2 (de) 1983-08-04
HU167597B (fr) 1975-11-28
PH11041A (en) 1977-10-25
CS190406B2 (en) 1979-05-31
SU496719A3 (ru) 1975-12-25
AU472734B2 (en) 1976-06-03
PL94207B1 (fr) 1977-07-30
YU97673A (en) 1982-02-25
JPS497237A (fr) 1974-01-22
JPS58131945A (ja) 1983-08-06
AR203822A1 (es) 1975-10-31
JPS6221343B2 (fr) 1987-05-12
CH569691A5 (fr) 1975-11-28
YU321279A (en) 1983-04-27
RO70892A (fr) 1982-02-26
SE399064B (sv) 1978-01-30
BG23001A3 (bg) 1977-05-20
DK142750B (da) 1981-01-12

Similar Documents

Publication Publication Date Title
IL42016A (en) History of dopamine and their preparation
KR100446893B1 (ko) Ｃｎｓ 장해 치료용 모노아민 재흡수 억제제
AU594788B2 (en) Pyridine ethanolamine derivatives
Salvatore et al. Synthesis of secondary amines
US5733936A (en) 6-dimethylaminomethyl-1-phenyl-cyclohexane compounds as pharmaceutical active ingredients
US6632955B1 (en) Optically active nitro alcohol derivatives, optically active amino alcohol derivatives, and process for preparing the same
US3551493A (en) Alkyl-and cycloalkyl-amino-propanol-cyclopentyl- and cyclopentenyl-phenol ethers
EP2285770B1 (fr) Processus pour la synthèse d arformotérol
AU702776B2 (en) Use of aryl-substituted cyclobutylalkylamines for treating obesity
WO2008035358A2 (fr) Procédé de préparation de la dapoxetine
US3987200A (en) Method for increasing cardiac contractility
IE894118L (en) An impoved process for the preparation of a valuable drug
MXPA02001372A (es) Derivados sustituidos de 2-dialquilaminoalquilbifenilo.
WO2004080934A2 (fr) Procede de preparation de derives de la phenetylamine
CA1061357A (fr) Phenylalkylamines
WO2023044027A1 (fr) Préparation d'énantiomères optiquement actifs d'amines de pipéronyle par résolution des sels diastéréomères
CA2396304A1 (fr) Derives d'aminomethyle-phenyle-cyclohexane substitues
US4028415A (en) Diphenylpropylamines
US2599001A (en) Nu, nu-disubstituted-beta-haloalkylamines
Chandrasekhar et al. Inexpensive protocol for reduction of imines to amines using polymethylhydrosiloxane (PMHS)
CN111777520B (zh) 多位取代的二甲氨基苯基乙酸类化合物的合成方法
EP0103990A1 (fr) Procédé pour la préparation de diarylamines
Krstić et al. Enantioselective organocatalytic addition of nitromethane to trifluoromethyl aryl ketimines promoted by electron‐rich bifunctional iminophosphoranes
IE60126B1 (en) 3-(2-aminoethyl) indole and -indoline derivatives, process for their preparation and pharmaceutical compositions containing them
US4918242A (en) Novel optically 1,3-phenoxypropylhalides